Sign In
Buy REGN
$663.09
-1.43 (-0.215%)
At Close: Jul 13, 2026
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Thursday, 09'th Jul 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Tuesday, 07'th Jul 2026
Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”
12:30pm, Tuesday, 07'th Jul 2026
On CNBC's Mad Dash segment on Monday, July 6, 2026, Jim Cramer made one of his most bullish biotech calls in years, arguing that the sector could be entering a new wave of mergers and acquisitions as
Here's Why Regeneron (REGN) is a Strong Value Stock
10:41am, Tuesday, 07'th Jul 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 07'th Jul 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Regeneron (REGN) is a Top Momentum Stock for the Long-Term
10:51am, Thursday, 02'nd Jul 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57%
03:45pm, Wednesday, 01'st Jul 2026
It might pull it off, provided several things fall right in place.
FDA selects Lilly, Regeneron for program to speed up review of new manufacturing facilities, CNBC reports
03:03pm, Monday, 29'th Jun 2026
The U.S. Food and Drug Administration has selected Eli Lilly and Regeneron , among seven companies, for a pilot program to accelerate reviews of new domestic pharmaceu
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
02:50pm, Monday, 29'th Jun 2026
Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the FDA's PreCheck pilot program. The FDA PreCheck
This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested
08:00pm, Saturday, 27'th Jun 2026
Parabilis saw its shares rise by more than SpaceX's shares did after its IPO. That doesn't mean it's guaranteed to succeed.
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
07:00am, Friday, 26'th Jun 2026
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.com, a leading investment platform for retail investors
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
04:05pm, Thursday, 25'th Jun 2026
TARRYTOWN, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2026 financial and operating results on Thursda
Is AbbVie a Buy After Its Purchase of Apogee?
09:53am, Thursday, 25'th Jun 2026
The pharmaceutical company gains a prospective blockbuster with the deal, but is it worth $10.9 billion?
Regeneron's Applications for gMG Drug Accepted by FDA and EMA
03:26pm, Tuesday, 23'rd Jun 2026
Regeneron's cemdisiran won FDA Priority Review and EMA filing acceptance for gMG, backed by phase III data and a potentially unique dosing schedule.
2 Underrated Weight Loss Stocks to Buy and Hold
02:45am, Tuesday, 23'rd Jun 2026
They look well-positioned to grab a slice of the fast-growing anti-obesity market.
